GHK-Cu is one of the most studied peptides in regenerative and dermatological research. First identified in human plasma in 1973, it has since accumulated a peer-reviewed literature spanning wound healing, tissue remodelling, collagen synthesis, hair follicle biology, and anti-inflammatory signalling — a breadth built over five decades of sustained scientific interest.
This article covers what GHK-Cu is, the mechanisms proposed in the research, what the published studies actually show, and what researchers working with it need to know.
What Is GHK-Cu?
GHK-Cu is the copper(II) complex of Glycyl-L-histidyl-L-lysine (GHK), a naturally occurring tripeptide consisting of three amino acids: glycine, histidine, and lysine. The peptide was first isolated from human plasma albumin by biochemist Loren Pickart in 1973, initially in the context of experiments on liver cell regeneration, where it was found to stimulate cell growth.
The copper-chelated form is considered the biologically active species. GHK has a high affinity for copper(II) ions — the histidine residue in particular coordinates the metal — and in physiological environments the peptide exists primarily as the GHK-Cu complex.
GHK occurs endogenously in human plasma, saliva, and urine. Plasma concentrations are measurably age-dependent: approximately 200 ng/mL in young adults, declining to around 80 ng/mL by age 60. This pattern of decline with age has made GHK-Cu of sustained interest to longevity and regenerative researchers.
Proposed Mechanisms
The research literature documents several overlapping mechanisms through which GHK-Cu appears to exert its effects.
Collagen and Extracellular Matrix Remodelling
Multiple studies have shown that GHK-Cu stimulates the synthesis of collagen, elastin, and glycosaminoglycans — the primary structural proteins of connective tissue and skin. It also appears to regulate matrix metalloproteinases (MMPs), enzymes that degrade extracellular matrix components. Research indicates GHK-Cu simultaneously promotes new ECM synthesis while facilitating the clearance of damaged matrix — a dual action that is mechanistically consistent with its observed effects in wound repair models.
Angiogenesis
Pickart et al. documented GHK-Cu's capacity to promote angiogenesis — the formation of new blood vessels — in tissue injury contexts. The proposed mechanism involves upregulation of vascular endothelial growth factor (VEGF) and related signalling. Injured tissue requires vascular support to regenerate, and GHK-Cu's angiogenic activity is considered one of the key mechanisms underlying its wound-healing research profile.
Anti-Inflammatory and Antioxidant Activity
Several studies have shown that GHK-Cu modulates inflammatory signalling, reducing expression of pro-inflammatory cytokines including TNF-α and IL-6. The copper component is understood to contribute antioxidant activity through superoxide dismutase (SOD) mimicry, which reduces oxidative stress in the tissue microenvironment — relevant in injury and repair contexts where oxidative load is elevated.
Gene Expression Regulation
More recent work using microarray analysis has revealed that GHK-Cu exerts broad regulatory effects on human gene expression. A 2014 analysis by Pickart and Margolina identified over 4,000 human genes responsive to GHK-Cu treatment, with effects concentrated in pathways relating to inflammation, tissue remodelling, and DNA repair. The authors observed that GHK-Cu appeared to shift gene expression profiles in aged or damaged tissue towards patterns more characteristic of younger, healthier cells. This finding has generated significant research interest but requires further mechanistic validation.
What the Published Studies Show
Wound Healing
The wound-healing literature on GHK-Cu is the most developed area of the compound's research profile. Animal model studies have consistently shown accelerated wound closure, improved dermal regeneration, and increased tensile strength of healed tissue in GHK-Cu-treated subjects compared to controls. Pickart's foundational work established a plausible mechanistic basis — angiogenesis, fibroblast activation, and ECM remodelling — that subsequent studies have built upon.
Skin and Dermal Research
A substantial body of dermatological research has examined GHK-Cu's effects on skin biology. Published studies have documented increases in skin thickness, collagen density, and dermal structural integrity in treated specimens. Research in aged skin models has shown outcomes consistent with the compound's proposed mechanisms on ECM synthesis and turnover. This area of the literature is among the more developed for GHK-Cu, though most studies are conducted in in vitro or animal models.
Hair Follicle Biology
GHK-Cu has been examined in the context of hair follicle research. In vitro and animal studies have shown that GHK-Cu treatment can enlarge hair follicle size and extend the anagen (active growth) phase of the hair cycle. The proposed mechanisms involve stimulation of follicular keratinocytes and dermal papilla cells, likely through growth factor signalling pathways — consistent with its general tissue-remodelling profile.
Lung and Systemic Tissue
A distinct thread in the GHK-Cu literature examines its effects in lung injury models. Rodent studies have shown protective effects against pulmonary damage and fibrosis, with proposed mechanisms involving cytokine modulation and MMP regulation. This extends the compound's potential research relevance beyond dermatological applications and into systemic tissue protection.
What Is Not Yet Established
The research limitations are significant and should inform any experimental design:
Human clinical trial data is limited — the majority of published studies are conducted in cell culture or animal models; human in vivo data remains sparse
The relative contributions of GHK and copper to observed effects have not been fully resolved — it is unclear how much of the activity is attributable to the peptide sequence versus the copper chelation
Optimal research parameters (concentration, vehicle, administration route) are not established in human models
Long-term systemic effects at research-relevant concentrations have not been studied at scale
The broad gene expression findings, while intriguing, require further mechanistic validation before causal conclusions can be drawn
Research Formats
GHK-Cu is available as a lyophilised powder for research applications. It reconstitutes readily in bacteriostatic water and is stable when stored correctly. Unreconstituted vials should be kept refrigerated. Once reconstituted, research solutions should be stored refrigerated and used within 28–30 days, away from light exposure.
